MGTX meiragtx.com: Rasio nilai perusahaan marang pendapatan

meiragtx.com (MGTX) - logo korporat

The EV/Sales ratio reflects market expectations for MeiraGTx Holdings plc (MGTX), where 1814.46 serves as the base parameter value. MeiraGTx Holdings plc (MGTX) treats rare vision and CNS pathologies, generating revenue through partnerships and the correction of genetic defects. The business relies on a closed-loop production cycle of riboswitch vectors. High demand inelasticity and patent protection ensure the asset remains independent of global economic fluctuations.

MGTX: Multiplikator EV/Sales MeiraGTx Holdings plc 23.11.2025 - 21.11.2026

MeiraGTx Holdings - rincian analitis lan metrik utama (MGTX)

- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
Analisis wiwitan perusahaan:MGTX (MeiraGTx)
Produk dadi MeiraGTx

MeiraGTx Holdings plc (MGTX) is spending significant reserves on clinical trials amid a shortage of current revenue. This indicator compares the total enterprise value, including debt, with sales volume, excluding the impact of the credit load. This allows for an objective assessment of the market value of assets relative to operational efficiency. The analysis helps detect revenue stagnation or artificial price stabilization in a timely manner. Monitor the enterprise value-to-revenue dynamics to identify risks of a sudden drop in quotes.

Pesaing langsung

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Intellia Therapeutics, Inc. (NTLA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Stoke Therapeutics Inc|BLFS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan WVE (Wave Life Sciences Corp)|Rasio total nilai perusahaan marang pendapatan Maze Therapeutics Corp|Sionna Therapeutics Inc - Nilai perusahaan marang pendapatan|PRME (primemedicine.com) - Nilai perusahaan marang volume dodolan|TSHA - Rasio nilai perusahaan marang pendapatan|QURE (uniQure) - Rasio nilai perusahaan marang pendapatan|Regenxbio (RGNX) - Rasio nilai perusahaan marang pendapatan|SLDB - Rasio total nilai perusahaan marang pendapatan|OCGN (Ocugen Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PACB|Rasio nilai perusahaan marang pendapatan Benitec (BNTC)|Design Therapeutics Inc - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rocket Pharma RCKT|Multiplikator EV/Sales 4DMT FDMT|LXEO - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Korro Bio Inc.|EDIT: Multiplikator EV/Sales|SLN - Rasio total nilai perusahaan marang pendapatan|PRQR (ProQR Therapeutics) - Multiplikator EV/Sales|codexis.com (CDXS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales SGMO|Multiplikator EV/Sales Nautilus Biotechnology, Inc. (NAUT)|Multiplikator EV/Sales MGX (Metagenomi Inc.)|Nilai bisnis marang pendapatan DTIL|Generation Bio Co. - Multiplikator EV/Sales|BOLD: Rasio nilai perusahaan marang pendapatan|XCUR (Exicure, Inc.) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan IMNN|Rasio nilai perusahaan marang pendapatan RXi Pharmaceuticals|mustangbio.com (MBIO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan TransCode (RNAZ)|Bionano Genomics Inc. - Rasio nilai perusahaan marang pendapatan|Applied DNA Sciences - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan bluebirdbio.com (BLUE)|IPA - Rasio nilai perusahaan marang pendapatan|OMGA - Multiplikator EV/Sales|OMIC (Singular Genomics Systems, Inc.) - Nilai perusahaan marang pendapatan|Regulus Therapeutics Inc - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan